Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
NCT00004008
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Ovarian Cancer
Interventions
DRUG:
bryostatin 1
Sponsor
University of Glasgow